566 related articles for article (PubMed ID: 33601307)
1. Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.
Croxford S; Emanuel E; Ibitoye A; Njoroge J; Edmundson C; Bardsley M; Heinsbroek E; Hope V; Phipps E
Public Health; 2021 Mar; 192():8-11. PubMed ID: 33601307
[TBL] [Abstract][Full Text] [Related]
2. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
[TBL] [Abstract][Full Text] [Related]
3. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
[TBL] [Abstract][Full Text] [Related]
4. Patterns of injecting and non-injecting drug use by sexual behaviour in people who inject drugs attending services in England, Wales and Northern Ireland, 2013-2016.
Heinsbroek E; Glass R; Edmundson C; Hope V; Desai M
Int J Drug Policy; 2018 May; 55():215-221. PubMed ID: 29523484
[TBL] [Abstract][Full Text] [Related]
5. Perceived availability and carriage of take-home naloxone and factors associated with carriage among people who inject drugs in England, Wales and Northern Ireland.
Spring C; Croxford S; Ward Z; Ayres R; Lord C; Desai M; Emanuel E; Vickerman P; Artenie A
Int J Drug Policy; 2022 Apr; 102():103615. PubMed ID: 35172254
[TBL] [Abstract][Full Text] [Related]
6. Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.
Lindqvist K; Wallmofeldt C; Holmén E; Hammarberg A; Kåberg M
Harm Reduct J; 2021 May; 18(1):52. PubMed ID: 33971892
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey.
Cullen KJ; Hope VD; Croxford S; Shute J; Ncube F; Parry JV
Epidemiol Infect; 2015 May; 143(7):1398-407. PubMed ID: 25119383
[TBL] [Abstract][Full Text] [Related]
8. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
9. Risk behaviours of homeless people who inject drugs during an outbreak of hepatitis C, Northern Ireland, 2016-2017.
Maisa A; Semple S; Griffiths A; Ngui SL; Verlander NQ; McCaughey C; Doherty L; Jessop L;
J Viral Hepat; 2019 Dec; 26(12):1377-1387. PubMed ID: 31328838
[TBL] [Abstract][Full Text] [Related]
10. The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland.
Trickey A; Croxford S; Emanuel E; Ijaz S; Hickman M; Kesten J; Thomas C; Edmundson C; Desai M; Vickerman P
Clin Infect Dis; 2022 Sep; 75(6):1073-1077. PubMed ID: 35184173
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: Nearly 40 years on.
Croxford S; Emanuel E; Shah A; Chau C; Hope V; Desai M; Ijaz S; Shute J; Edmundson C; Harris RJ; Delpech V; Phipps E
HIV Med; 2022 Oct; 23(9):978-989. PubMed ID: 35352446
[TBL] [Abstract][Full Text] [Related]
12. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis.
McAuley A; Palmateer NE; Goldberg DJ; Trayner KMA; Shepherd SJ; Gunson RN; Metcalfe R; Milosevic C; Taylor A; Munro A; Hutchinson SJ
Lancet HIV; 2019 May; 6(5):e315-e324. PubMed ID: 30981674
[TBL] [Abstract][Full Text] [Related]
13. How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.
Nguyen TT; Hoang GT; Nguyen DQ; Nguyen AH; Luong NA; Laureillard D; Nagot N; Des Jarlais D; Duong HT; Nham TTT; Khuat OTH; Pham KM; Le MS; Michel L; Rapoud D; Le GM
Harm Reduct J; 2022 Jan; 19(1):6. PubMed ID: 35090482
[TBL] [Abstract][Full Text] [Related]
14. Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs.
Kesten JM; Holland A; Linton MJ; Family H; Scott J; Horwood J; Hickman M; Telfer M; Ayres R; Hussey D; Wilkinson J; Hines LA
Int J Drug Policy; 2021 Dec; 98():103391. PubMed ID: 34343945
[TBL] [Abstract][Full Text] [Related]
15. Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms.
Hope VD; Iversen J; Cullen KJ; Parry JV; Maher L; Nucbe F
Int J Drug Policy; 2017 Aug; 46():28-33. PubMed ID: 28586700
[TBL] [Abstract][Full Text] [Related]
16. The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland.
Genberg BL; Astemborski J; Piggott DA; Woodson-Adu T; Kirk GD; Mehta SH
Drug Alcohol Depend; 2021 Apr; 221():108584. PubMed ID: 33607497
[TBL] [Abstract][Full Text] [Related]
17. A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.
Hope VD; Harris RJ; Vickerman P; Platt L; Shute J; Cullen KJ; Ijaz S; Mandal S; Ncube F; Desai M; Parry JV
Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482265
[TBL] [Abstract][Full Text] [Related]
18. Adverse health outcomes among people who inject drugs who engaged in recent sex work: findings from a national survey.
Emanuel E; Slater L; Croxford S; Edmundson C; Ibitoye A; Njoroge J; Ijaz S; Hope V; Platt L; Phipps E; Desai M
Public Health; 2023 Dec; 225():79-86. PubMed ID: 37922590
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya.
Doshi S; Kingston H; Tseng AS; Chohan BH; Sambai B; Guthrie BL; Monroe-Wise A; Mbogo LW; Masyuko S; Tram KH; Sinkele W; Macharia P; Bukusi D; Herbeck JT; Farquhar C
Harm Reduct J; 2023 Feb; 20(1):21. PubMed ID: 36823596
[TBL] [Abstract][Full Text] [Related]
20. The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals.
Mistler CB; Curley CM; Rosen AO; El-Krab R; Wickersham JA; Copenhaver MM; Khati A; Shrestha R
J Community Health; 2021 Oct; 46(5):960-966. PubMed ID: 33770334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
